Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a …

SN Faust, R Haynes, CE Jones, N Staplin… - The Lancet Child & …, 2024 - thelancet.com
Background Paediatric multisystem inflammatory syndrome temporally associated with
SARS-CoV-2 (PIMS-TS), also known as multisystem inflammatory syndrome in children (MIS …

Current Treatment Guidelines of SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children: A Literature Review and Expert Opinion

A Ghodsi, M Sarabi, A Malek… - Journal of Child …, 2021 - thieme-connect.com
Multisystem inflammatory syndrome in children (MIS-C) is a systemic disorder that seems to
be associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since …

[HTML][HTML] A young child with pediatric multisystem inflammatory syndrome successfully treated with high-dose immunoglobulin therapy

Y Mohri, M Shimizu, T Fujimoto, Y Nishikawa, A Ikeda… - IDCases, 2022 - Elsevier
Pediatric multisystem inflammatory syndrome (MIS-C) is a disease that presents mainly in
older children after coronavirus disease 2019 (COVID-19) and is associated with Kawasaki …

[HTML][HTML] Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies

Y Tang, W Li, M Baskota, Q Zhou, Z Fu, Z Luo… - Translational …, 2021 - ncbi.nlm.nih.gov
Background Many cases have been reported recently on multisystem inflammatory
syndrome in children (MIS-C), a newly emerged disease that seemed to correlate with …

Trends in treatments for multisystem inflammatory syndrome in children (MIS-C), United States, February 2020–July 2021

JY Abrams, ED Belay, S Godfred-Cato… - Clinical Infectious …, 2022 - academic.oup.com
Background Multisystem inflammatory syndrome in children (MIS-C) is a novel severe
postinfectious condition associated with severe acute respiratory syndrome coronavirus 2 …

Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection

S Patnaik, MK Jain, S Ahmed, AK Dash, RK P… - Rheumatology …, 2021 - Springer
Multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19 is a
recently recognised potentially life-threatening entity. There is limited data on post-MIS-C …

Post–COVID-19 multisystem inflammatory syndrome in children

MM Kim, S Murthy, RD Goldman - Canadian Family Physician, 2021 - cfp.ca
Question The effect of acute coronavirus disease 2019 (COVID-19) on morbidity and
mortality in children has been relatively small. If a child presents to my office with persistent …

[HTML][HTML] COVID-19: multisystem inflammatory syndrome in children (MIS-C) management and outcome

MBF Son, K Friedman, SL Kaplan, R Sundel… - Up to Date, 2021 - medilib.ir
SETTING OF CARE—The appropriate setting of care is determined by the severity of illness,
risk of complications, and adequacy of follow-up.● Inpatient management–Essentially all …

Best practice recommendations for the diagnosis and management of children with pediatric inflammatory multisystem syndrome temporally associated with SARS …

LJ Schlapbach, MC Andre, S Grazioli, N Schöbi… - Frontiers in …, 2021 - frontiersin.org
Background: Following the spread of the coronavirus disease 2019 (COVID-19) pandemic a
new disease entity emerged, defined as Pediatric Inflammatory Multisystem Syndrome …

Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19

LR Feldstein, MW Tenforde, KG Friedman, M Newhams… - Jama, 2021 - jamanetwork.com
Importance Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C)
may inform efforts to improve health outcomes. Objective To compare clinical characteristics …